Early detection of non-compliance in Wilson's disease by consecutive copper determination in cerebrospinal fluid

Journal of Neurology Neurosurgery and Psychiatry

Volumn 69, Issue 5, 2000, Pages 701-702

  Stuerenburg, H J ^a   Eggers, C ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; COPPER; PENICILLAMINE; ZINC;

ATAXIA; ATTENTION DEFICIT DISORDER; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; COPPER BLOOD LEVEL; COPPER METABOLISM; DIET RESTRICTION; DIPLOPIA; DYSARTHRIA; EVALUATION AND FOLLOW UP; HUMAN; LETTER; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL DISORDER; WILSON DISEASE;

ADULT; BRAIN; COPPER; HEPATOLENTICULAR DEGENERATION; HUMAN; MALE; TIME FACTORS;

EID: 0033793003     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.69.5.701     Document Type: Letter

References (5)

1. CSF copper concentration: A new parameter for diagnosis and monitoring therapy of Wilson's disease with cerebral manifestation
2. Does CSF copper level in Wilson disease reflect copper accumulation in the brain
3. Wilson's disease with cerebral manifestation: Monitoring therapy by CSF copper concentration
4. Determinants of the copper concentration in CSF
5. CSF copper concentrations, blood-brain barrier function and coeruloplasmin synthesis during the treatment of Wilson's disease